4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-050588
CEO sold 10,395 shares at $9.51 ($98,856)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PIMSTONE SIMON N. CEO | 2019-09-20 | Sale | −10,395 | $9.51 | $98,856 | 258,122 | D: show line 1 in the form |
| Open-market sales · 10,395 sh · avg $9.51 · $98,856 | |||||||
Loading xslF345X03/doc4.xml…